Synchrony Financial Form 4 insider transactions

NYSE
Director Leonard Alves Paget acquired dividend equivalent units on May 15, 2026, valued at $71.38 per unit.
NYSE
Synchrony Financial executive Curtis Howse reported a transaction involving 8,436 shares of common stock on May 1, 2026, executed under a Rule 10b5-1 trading plan.
NYSE
Arthur W. Coviello Jr., a Director at Synchrony Financial, reported a transaction involving the purchase of 4,000 shares of common stock on May 1, 2026, under a pre-established Rule 10b5-1 trading plan.
NYSE
Alberto Casellas, EVP, CEO--Health & Wellness at Synchrony Financial, executed a 10b5-1 plan transaction involving the acquisition and disposition of common stock.
NYSE
Synchrony Financial Director Leonard Alves Paget acquired 883 shares of common stock on March 31, 2026, at a price of $68.02 per share.
NYSE
Synchrony Financial Director Roy A. Guthrie reported the acquisition of 883 shares of common stock on March 31, 2026, valued at $68.02 per share.
NYSE
Jeffrey G. Naylor, a Director at Synchrony Financial, reported the acquisition of 1,343 shares of common stock.
NYSE
Synchrony Financial Director Daniel O. Colao acquired 883 shares of common stock through restricted stock units vesting on March 31, 2026.
NYSE
Director Fernando Aguirre of Synchrony Financial has acquired 883 shares of common stock through restricted stock units, with full vesting expected in March 2027.
NYSE
Synchrony Financial Director Ellen M. Zane acquired 883 shares of common stock through restricted stock units vesting, increasing her direct beneficial ownership.
NYSE
Deborah G. Ellinger, a Director at Synchrony Financial, reported the acquisition of 883 shares of common stock on March 31, 2026, at a price of $68.02 per share.
NYSE
Kamila Chytil, a Director at Synchrony Financial, acquired 883 shares of common stock on March 31, 2026, valued at $68.02 per share.
NYSE
Arthur W. Coviello Jr., a Director at Synchrony Financial, acquired 883 shares of common stock on March 31, 2026, at a price of $68.02 per share.
NYSE
Laurel Richie, a Director at Synchrony Financial, acquired 883 shares of common stock on March 31, 2026, as disclosed in a Form 4 filing.
NYSE
Director P.W. Parker of Synchrony Financial acquired 883 shares of common stock on March 31, 2026, valued at $68.02 per share.
NYSE
A Synchrony Financial officer reported the acquisition of restricted stock units and subsequent sales, including tax withholding, under a pre-arranged trading plan.
NYSE
Synchrony Financial's EVP, CEO--Digital, Bart Schaller, reported the acquisition of shares from RSU vesting, followed by tax-related dispositions and a planned sale.
NYSE
Synchrony Financial's EVP, Chief Technology and Operating Officer, Carol Juel, reported the acquisition of restricted stock units, tax-related dispositions, and a sale of common stock.
NYSE
Synchrony Financial's EVP, CEO of Home & Auto, Curtis Howse, reported the acquisition of restricted stock units, subsequent tax-related share withholding, and a sale of shares under a 10b5-1 plan.
NYSE
Synchrony Financial's EVP, Chief Risk and Legal Officer, Jonathan S. Mothner, reported the acquisition of restricted stock units and the disposition of shares for tax purposes.
NYSE
Darrell Owens, an officer at Synchrony Financial, reported the acquisition of restricted stock units and subsequent sales of common stock, including shares withheld for tax obligations.
NYSE
Synchrony Financial officer Amy Tiliakos reported the acquisition of restricted stock units and the disposition of shares for tax withholding.
NYSE
Synchrony Financial's EVP and CFO, Brian J. Sr. Wenzel, reported the vesting of restricted stock units, subsequent tax withholding, and sales of common stock under a Rule 10b5-1 plan.
NYSE
Synchrony Financial EVP Alberto Casellas reported the acquisition of restricted stock units, shares withheld for taxes, and a sale of common stock, all pursuant to pre-arranged plans.
NYSE
Synchrony Financial's President and CEO, Brian D. Doubles, executed pre-planned sales of common stock and exercised options, reducing his direct beneficial ownership to 829,222 shares.
NYSE
Synchrony Financial Director Jeffrey G. Naylor acquired 190 dividend equivalent units on February 17, 2026, increasing his direct beneficial ownership to 62,677 units.
NYSE
Synchrony Financial director Daniel O. Colao accrued 14 dividend equivalent units, valued at $72.31 each, on February 17, 2026.
NYSE
Synchrony Financial's EVP, Chief Technology and Operating Officer, Carol Juel, reported the sale of 44,411 common shares and the acquisition of 243 dividend equivalent units.
NYSE
Synchrony Financial's EVP & CEO of Diversified & Value, Courtney Gentleman, reported the sale of 12,045 common shares and the acquisition of 74 dividend equivalent units.
NYSE
Synchrony Financial's EVP, CEO of Health & Wellness, Alberto Casellas, executed pre-planned transactions, selling 41,514 common shares while acquiring others.